These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 20159811)

  • 1. Significance of sentinel lymph node micrometastases in patients with breast cancer.
    Gyorki DE; Henderson MA
    J Clin Oncol; 2010 Mar; 28(9):e139; author reply e141-2. PubMed ID: 20159811
    [No Abstract]   [Full Text] [Related]  

  • 2. Micrometastases and isolated tumor cells in breast cancer are indeed associated with poorer outcome.
    van Diest PJ; de Boer M; van Deurzen CH; Tjan-Heijnen VC
    J Clin Oncol; 2010 Mar; 28(9):e140; author reply e141-2. PubMed ID: 20159803
    [No Abstract]   [Full Text] [Related]  

  • 3. [Detailed pathological examination of the sentinel lymph nodes in order to detect micrometastases: no clinical relevance in patients with breast cancer].
    Meijnen P; Peterse JL; Nieweg OE; Rutgers EJ
    Ned Tijdschr Geneeskd; 2004 Dec; 148(49):2428-32. PubMed ID: 15626306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The clinical significance of axillary lymph node micrometastases in breast cancer.
    Sakorafas GH; Geraghty J; Pavlakis G
    Eur J Surg Oncol; 2004 Oct; 30(8):807-16. PubMed ID: 15336724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical outcome of patients with lymph node-negative breast carcinoma who have sentinel lymph node micrometastases detected by immunohistochemistry.
    Tez M; Tez S
    Cancer; 2005 Oct; 104(8):1779-80; author reply 1780. PubMed ID: 16104028
    [No Abstract]   [Full Text] [Related]  

  • 6. Sentinel node biopsy before neoadjuvant chemotherapy for determining axillary status and treatment prognosis in locally advanced breast cancer.
    Cox CE; Cox JM; White LB; Stowell NG; Clark JD; Allred N; Meyers M; Dupont E; Furman B; Minton S
    Ann Surg Oncol; 2006 Apr; 13(4):483-90. PubMed ID: 16523361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Axillary lymph node dissection for sentinel lymph node micrometastases may be safely omitted in early-stage breast cancer patients: long-term outcomes of a prospective study.
    Langer I; Guller U; Viehl CT; Moch H; Wight E; Harder F; Oertli D; Zuber M
    Ann Surg Oncol; 2009 Dec; 16(12):3366-74. PubMed ID: 19760047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sentinel lymph node biopsy in breast cancer patients: the medical oncology perspective.
    Catzeddu T; Bertelli G; Del Mastro L; Venturini M
    J Surg Oncol; 2004 Mar; 85(3):129-32. PubMed ID: 14991884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of non-SN involvement in patients with SN isolated tumor cells or micrometastases.
    Pesce C; Balch C; Jacobs L
    Breast Dis; 2010; 31(2):99-106. PubMed ID: 21368372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
    Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
    J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biological significance of occult micrometastases in histologically negative axillary lymph nodes in breast cancer patients using the recent American Joint Committee on Cancer breast cancer staging system.
    Kahn HJ; Hanna WM; Chapman JA; Trudeau ME; Lickley HL; Mobbs BG; Murray D; Pritchard KI; Sawka CA; McCready DR; Marks A
    Breast J; 2006; 12(4):294-301. PubMed ID: 16848838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Additional axillary metastases and stage migration in breast cancer patients with micrometastases or submicrometastases in sentinel lymph nodes.
    van Rijk MC; Peterse JL; Nieweg OE; Oldenburg HS; Rutgers EJ; Kroon BB
    Cancer; 2006 Aug; 107(3):467-71. PubMed ID: 16804924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Re: Sakorafas GH, Geraghty J, Pavlakis G. The clinical significance of axillary lymph node micrometastases in breast cancer. Eur J Surg Oncol 2004;30(8):807-16.
    Meijnen P; Rutgers EJ
    Eur J Surg Oncol; 2005 Oct; 31(8):927. PubMed ID: 15951151
    [No Abstract]   [Full Text] [Related]  

  • 14. [Importance of lymph node involvement in breast carcinoma for the oncologist].
    Cerny T
    Zentralbl Chir; 2000; 125(10):813-6. PubMed ID: 11098575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sentinel node biopsy: interpretation and management of patients with immunohistochemistry-positive sentinel nodes and those with micrometastases.
    Rutgers EJ
    J Clin Oncol; 2008 Feb; 26(5):698-702. PubMed ID: 18258976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current status of sentinel lymph node biopsy in early breast cancer.
    Jatoi I
    Int J Fertil Womens Med; 2004; 49(5):215-21. PubMed ID: 15633478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of sentinel lymph node (SLN) status in primary breast cancer by prospective use of immunohistochemistry increases the rate of micrometastases and isolated tumour cells: analysis of 174 patients after SLN biopsy.
    Rydén L; Chebil G; Sjöström L; Pawlowski R; Jönsson PE
    Eur J Surg Oncol; 2007 Feb; 33(1):33-8. PubMed ID: 17174513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Axillary and extra-axillary lymph node recurrences after a tumor-negative sentinel node biopsy for breast cancer using intralesional tracer administration.
    van der Ploeg IM; Kroon BB; Antonini N; Valdés Olmos RA; Rutgers EJ; Nieweg OE
    Ann Surg Oncol; 2008 Apr; 15(4):1025-31. PubMed ID: 18219534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of tumour involvement in remaining axillary lymph nodes when the sentinel node in a woman with breast cancer contains metastases.
    Nos C; Harding-MacKean C; Fréneaux P; Trie A; Falcou MC; Sastre-Garau X; Clough KB
    Br J Surg; 2003 Nov; 90(11):1354-60. PubMed ID: 14598414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical implications of axillary sentinel lymph node 'micrometastases' in breast cancer.
    Krauth JS; Charitansky H; Isaac S; Bobin JY
    Eur J Surg Oncol; 2006 May; 32(4):400-4. PubMed ID: 16504456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.